GLPwatch
Trials (2101)
Page 23 of 36.
- Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
- The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
- A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss
- Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
- Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
- Effects of Liraglutide on Body Surface Gastric Mapping
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
- The Long COVID Treatment Trial
- PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
- A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
- Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.
- DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy
- To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c
- Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
- A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
- Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
- Glucagon-like Peptide (GLP) Utilization and Safety
- Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
- Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
- A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
- A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
- Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
- The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
- Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
- A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
- Tailored Exercise Training Study Among Adults With HFpEF
- Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
- GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)
- Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
- The Effect of Liraglutide on Pancreatic Hormones and Its Size
- The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
- Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
- Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
- A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
- A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
- Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
- Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
- Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity
- Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
- A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese
- A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China
- Effect of LIXIsenatide on the Renal System
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
- Efficacy and Safety of Tirzepatide for Weight Management
- The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
- A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
- A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
- Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
- A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
- Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
- A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus